Tecan launches Cavro® Magni Flex for next generation automated liquid handling development (560-19)
UNITED KINGDOM / AGILITYPR.NEWS / November 14, 2019 / Tecan unveiled its new Cavro® Magni Flex OEM robotic liquid handling instrument development platform at this year’s AACC Annual Scientific Meeting & Clinical Lab Expo. This modular and scalable solution is intended for low to medium throughput workflows, offering the flexibility and functionality to quickly and easily create innovative automation systems for virtually any life sciences application, from immunoassay processing to molecular diagnostics.
The Cavro Magni Flex provides the core robotic architecture for the development of complete automation solutions, with a highly configurable workdeck designed to accommodate a wide range of labware formats and devices to meet specific workflow requirements. A variety of carriers, cutouts and custom grids are available to create any number of layouts, and the system is available with a choice of two, four or eight independent pipetting channels. The platform’s liquid handling arm offers variable tip spacing capabilities – to suit different labware types and enable reformatting activities – and can act as both a pipettor and gripper, optimizing use of the available space.
The Cavro Magni Flex takes advantage of the exceptional quality and robustness of the Tecan Cavro range of OEM liquid handling components to provide a comprehensive, modular liquid handling framework that allows seamless integration into any system. Supplied with Tecan’s MAPlinx™ development software kit – which includes high level functional commands for straightforward programming, a worktable editor with virtual library and drag-and-drop features, and a 3D simulator to simplify software testing – the Cavro Magni Flex aims to accelerate instrument development and time to market.
Joe Rotter, Vice President, Global Marketing for Life Science Components at Tecan, commented: “The Cavro Magni Flex is designed to stay ahead of the ever changing needs of our partners and the evolving market. It offers advanced software development capabilities and exceptional design flexibility to provide easy access to liquid handling automation for faster instrument development. In the future, it will enable customers to monitor their install base remotely, for superior performance monitoring and implementation of productivity enhancements.”
To learn more about Tecan’s Magni Flex, visit www.tecan.com/cavro-magni-flex-modular-and-scalable-development-platform. You can also contact your local Tecan representative about a Lunch & Learn session, where a Tecan team of experts will bring lunch and Tecan Cavro components – including the Cavro Magni Flex – to your site, providing the opportunity to interact with the platform and discuss your project in detail.
About Us
About Tecan
Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2018, Tecan generated sales of CHF 594 million (USD 606 million; EUR 516 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TECN; ISIN CH0012100191).
Über Tecan
Tecan (www.tecan.com) ist ein weltweit führender Anbieter von Laborinstrumenten und Lösungen für die Branchen Biopharma, Forensik und Klinische Diagnostik. Das Unternehmen ist auf Entwicklung, Herstellung und Vertrieb von Automatisierungslösungen für Laboratorien im Life-Science-Bereich spezialisiert. Die Kunden von Tecan sind Pharma- und Biotechnologieunternehmen, Forschungs-abteilungen von Universitäten sowie forensische und diagnostische Laboratorien. Als Originalgeräte-hersteller (OEM) ist Tecan auch führend in der Entwicklung und Herstellung von OEM-Instrumenten und Komponenten, die vom jeweiligen Partnerunternehmen vertrieben werden. Tecan wurde 1980 in der Schweiz gegründet. Das Unternehmen verfügt über Produktions-, Forschungs- und Entwicklungs-stätten in Europa und in Nordamerika. In 52 Ländern unterhält es ein Vertriebs- und Servicenetz. Im Jahr 2016 erzielte Tecan einen Umsatz von CHF 594 Mio. (USD 606 Mio.; EUR 516 Mio.). Die Namenaktien der Tecan Group werden an der SIX Swiss Exchange gehandelt (TECN; ISIN CH0012100191).
Contacts